Navigation Links
Prous Institute Presents Innovative Approach to Drug Discovery
Date:2/26/2009

BARCELONA, February 26 /PRNewswire/ -- Prous Institute for Biomedical Research today presented its strategies for drug discovery on its newly designed website (http://www.prousresearch.com). A large computational project with basic research support and broad disease coverage is being developed at Prous Institute under the broad-based Epistemic Drug Discovery(R) project.

President and C.E.O. of the Institute, Dr. J.R. Prous, explained that "We are committed to accelerating biomedical knowledge by the synchronization of powerful expert knowledge-based systems and basic research. This next-generation drug R&D force is expected to increase the efficiency and efficacy of core drug R&D processes, facilitating continuous innovation."

Two main drug discovery programs are being developed at the Institute. One is focused on the design, synthesis and biological evaluation of new small-molecule modulators of autophagy as therapeutic agents for cancer and neurodegeneration (Alzheimer's disease and Huntington's disease). Another program looks at target-driven drug discovery from natural sources, covering type 2 diabetes, psychological stress and asthma. The Institute's computational tools enable the in silico screening of thousands of natural products in a rapid, reliable and cost-effective manner, as well as the discovery of new targets and new uses for existing drugs.

J.R. Prous commented "our approach is bringing us closer to drug discovery, and the Institute expects to have several compounds in preclinical evaluation by the end of this year (2009)."

About Prous Institute for Biomedical Research

Prous Institute is a privately-held research-driven organization committed to the discovery and development of innovative therapies through the use of its powerful computational tools and the support of basic research. Prous Institute also fosters the development of prediction technologies used for regulatory and industry safety screening programs. Prous Institute receives several government grants and actively collaborates with academia and industry.

For more information, please contact Prous Institute: Xavier Mensa E-mail: info@prousresearch.com, Tel: +34-93-457-17-95, or visit http://www.prousresearch.com


'/>"/>
SOURCE Prous Institute for Biomedical Research, S.A.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
2. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
3. UKs Institute of Cancer Research and Silicon Graphics Establish Long-Term Alliance to Design and Outfit World-Class Network Biology Lab
4. American Institute for Medical and Biological Engineering Appoints Dr. Gualberto Ruano to College of Fellows
5. Baltimore LASIK Surgeon Roy Chuck, MD, PhD of the Wilmer Eye Institute at Johns Hopkins Lists with Trusted LASIK Surgeons
6. Agendias Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
7. IDRI Collaborates with the Brazilian Butantan Institute To Develop Novel Vaccines Against Leishmaniasis
8. National Cancer Institute: Battling Cancer and a Recession
9. The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates
10. Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System
11. Cascades Technologies, Inc. and SAIC Team on $19 Million Contract with National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 - New FDA action date of ... FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast has ... indicated for the treatment of signs and symptoms of dry eye ... potential to be the only product approved in the U.S. in the past decade indicated ...
(Date:2/4/2016)... ... February 04, 2016 , ... Shimadzu Scientific Instruments will showcase ... demos and poster sessions, and present on the analysis of mycotoxins and medical ... 6 to 10 at the Georgia World Congress Center in Atlanta, Georgia. ...
(Date:2/4/2016)... 4, 2016 Beike Biotechnology, the ... attended a ceremony in late 2015 to mark their ... in 2016. --> --> ... for Personalized Cell Therapy" was hosted by the Shenzhen ... both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... Columbia and MENLO PARK, Calif. ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused ... announced that it will present at the 18 th ... February 8, 2016 at 10:00 a.m. EST in ... , DelMar,s president and CEO, will provide an update on ...
Breaking Biology Technology:
(Date:2/3/2016)... --> --> Fourth quarter 2015:   ... with fourth quarter of 2014. Gross margin was 46% (32). ... Earnings per share increased to SEK 6.39 (loss: 0.49). ... --> --> January to ... up 1,142% compared with 2014. Gross margin was 43% (31). ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/1/2016)... Rising sales of consumer electronics ... intuitive gesture control market size ... consumer electronics coupled with new technological advancements to drive ... through 2020   --> ... advancements to drive global touchfree intuitive gesture control market ...
Breaking Biology News(10 mins):